ARCUTIS BIOTHERAPEUTICS, INC. Voting Outcome
Historical shareholder voting results from retained filings, including every disclosed proposal and director nominee. Vote counts are as filed, not split-adjusted, and displayed in K/M/B/T. — means the category was not reported or no vote was held. Frequency votes preserve each choice. All retained years remain available through pagination.
| Meeting / report date | Proposal / nominee | Outcome | For (shares) | Against (shares) | Abstain (shares) | Withheld (shares) | Broker non-votes (shares) | Filed | Frequency choices (shares) | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |